Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
Non-small cell lung cancer (NSCLC) was usually associated with poor prognosis and invalid therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to screen reliable biomarkers, es...